Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Kimberly Crosland

Pediatrics Richmond Hill, GA Medical Doctor

NPI 1861637449 CMS profile 2010988

10055 Ford Ave Ste 4A, Richmond Hill, GA 31324

Open in the dashboard

General payments

$1,824

92 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kimberly Crosland of Richmond Hill, GA is reported in the CMS Open Payments database as having received $1,824 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $410 16
2024 General $264 12
2023 General $438 22
2022 General $338 19
2021 General $257 15
2020 General $116 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kimberly Crosland
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Kimberly Crosland were reported at $410. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Kimberly Crosland Pediatrics median Middle half National median
2019 $0 $86 $31–$183 $163
2020 $116 $49 $22–$110 $114
2021 $257 $68 $27–$158 $132
2022 $338 $77 $30–$173 $149
2023 $438 $88 $33–$190 $160
2024 $264 $94 $34–$206 $164
2025 $410 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Corium, Inc. $501 24 payments
  2. Tris Pharma Inc $237 14 payments
  3. Sanofi Pasteur Inc. $175 10 payments
  4. Sobi, Inc $160 9 payments
  5. Baxter Healthcare $124 1 payment
  6. Ironshore Pharmaceuticals Inc. $118 6 payments
  7. Pfizer Inc. $91 4 payments
  8. Merck Sharp & Dohme Corporation $80 5 payments
  9. Seqirus USA Inc $59 3 payments
  10. Adlon Therapeutics L.P. $58 3 payments
  11. Other $221 13 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $1,700 91 payments
  2. Long term medical supply or device loan $124 1 payment
Products named General payments · program years 2020–2025
  1. Azstarys $501 24 payments
  2. SYNAGIS $160 9 payments
  3. VAXELIS $124 7 payments
  4. Hillrom - Spot Vision Screener $124 1 payment
  5. Dyanavel XR Adhd $99 5 payments
  6. Dyanavel XR Adhd $94 6 payments
  7. PREVNAR 20 $91 4 payments
  8. MENQUADFI $87 5 payments
  9. GARDASIL 9 $80 5 payments
  10. JORNAY PM $77 4 payments
  11. Other $997 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record